World Class Speakers

 

The European Antibody Congress agenda will feature 300+ speakers across multiple streams and co-located events.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.

 

2018 Speakers confirmed to date

 

Jenny Alltoft, Head of Global Biosimilars, Pfizer

Jenny Alltoft at European Antibody Congress

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at European Antibody Congress

Dani Bach, Director, Healthcare Ventures, Touchstone Ventures

Dani Bach at European Antibody Congress

Jonathan Back, Deputy Director, Project Team Lead, Drug Discovery, Glenmark Pharmaceuticals SA

Jonathan Back at European Antibody Congress

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis

Karoline Bechtold Peters at European Antibody Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Stephen Beers, Associate Professor, University Of Southampton

Phil Bland-Ward, Chief Scientific Officer, Crescendo Biologics Ltd

Phil Bland-Ward at European Antibody Congress

Dr Ezio Bonvini, CSO, Macrogenics

Louis Boon, Chief Scientific Officer, Bioceros

Ingrid Bourges, Clinical Assessor, Federal Agency for Medicines and Health Products

Ingrid Bourges at European Antibody Congress

Frank Brennan, Head of Non-Clinical Toxicology and PK/PD (Immunology), UCB Pharma

Alessandro Brigo, Principal Scientist in Pharma Research and Early Development and Toxicology Project Leader, Roche Pharmaceuticals

Alessandro Brigo at European Antibody Congress

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Jack Brown, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals Inc

Jack Brown at European Antibody Congress

Sebastian Bunk, Research Director, Immunology, Immatics Biotechnologies GmbH

Patrick Burke, Associate Director, Seattle Genetics Inc

Martina Canestraro, Senior Scientist Cell Biology, Immunocore Ltd

Paul Carter, Senior Director and Staff Scientist, Antibody Engineering, Genentech

Kieran Casey, Business Development Manager, Services, Bioreclamation IVT

Brian Champion, CSO, Psioxus Therapeutics Ltd

Brian Champion at European Antibody Congress

Deborah Charych, Executive Director, Nektar Therapeutics

Deborah Charych at European Antibody Congress

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Andre Choo at European Antibody Congress

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury at European Antibody Congress

Daniela Cipolletta, Investigator III, Novartis

Jeannick Cizeau, Director of Research, Eleven Biotherapeutics

Nathalie Corvaïa, Managing Director, Institut De Recherche Pierre Fabre

Nathalie Corvaïa at European Antibody Congress

Prentice Curry, Vice President Quality and Operations, Kite Pharma Inc

Prentice Curry at European Antibody Congress

Dr William Dall'Acqua, VP, R&D, MedImmune

Igor D'Angelo, Senior Scientist and Functional Lead, Amgen Inc

Lee Dawson, Senior Scientist, Molecular Pathology Group, Asterand Bioscience

Lee Dawson at European Antibody Congress

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Madiha Derouazi, Chief Executive Officer, Amal Therapeutics

Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals

Richard DiCicco at European Antibody Congress

Claire Dobson, Associate Director of Antibody Discovery and Protein Engineering, MedImmune

Claire Dobson at European Antibody Congress

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at European Antibody Congress

Wendel Doubleday, Senior Director of Chemical Development, Seattle Genetics Inc

Wendel Doubleday at European Antibody Congress

Roman Drai, Geropharm

Roman Drai at European Antibody Congress

Prof Stefan Duebel, Director, Braunschweig University of Technology

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Stephan Ewert, Senior Investigator, Novartis Pharma AG

Kalveer Flora, Specialist Pharmacist Rheumatology & Biosimilars, London North West Healthcare Nhs Trust

Kalveer Flora at European Antibody Congress

Agnete Fredriksen, President and Chief Scientific Officer, Vaccibody As

Per Ola Freskgard, Vice Director & Expert Scientist, Roche Innovation Center Basel

Lothar Germeroth, Senior Vice President and Managing Director, Juno Therapeutics

Lothar Germeroth at European Antibody Congress

Dr David Gilham, Vice President of Research and Development, Celyad

Dr David Gilham at European Antibody Congress

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at European Antibody Congress

Eric Halioua, President and Chief Executive Officer, PDC*line pharma SA

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Andreas Herrmann, Chief Executive Officer, Valerius Biopharma

Andreas Herrmann at European Antibody Congress

Matthew Hewitt, Director, Tumour Immunology & Microenvironment, Bellicum Pharmaceuticals

Stuart Hicks, Associate Director, ImmunoGen Inc

Stuart Hicks at European Antibody Congress

Michael Hust, Group Leader, Technical University of Braunschweig

Clare Jacklin, Director, National Rheumatoid Arthritis Society

Clare Jacklin at European Antibody Congress

Christopher Jewell, Associate Professor & Damon Runyon-Rachleff Innovator, University of Maryland

Christopher Jewell at European Antibody Congress

Kevin Johnson, Partner, Medicxi

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Peter Joyce, CEO, Grey Wolf Therapeutics

Meelis Kadaja, Director of Business Development, Icosagen Cell Factory Ltd

Robert Kelley, Principal Scientist, Genentech

Robert Kelley at European Antibody Congress

James Kent, NHS England

James Kent at European Antibody Congress

Shirin Khambata Ford, Executive Director of Oncology Biomarker and Diagnostics Leader, Merck Oncology

Shirin Khambata Ford at European Antibody Congress

Houng Kim, head of the strategy and operations division, Celltrion Healthcare

Houng Kim at European Antibody Congress

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

David Klatzmann, Professor, Pierre et Marie Curie University and Medical School

David Klatzmann at European Antibody Congress

Roland Kontermann, Professor Of Biomedical Engineering, University of Stuttgart

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Suzette Kox, Senior Director Of International For Biosimilar Medicines Group, Medicines for Europe A.I.S.B.L.

Suzette Kox at European Antibody Congress

Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel

Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Emma Lees, Vice President,, N.I.B.R.

Emma Lees at European Antibody Congress

Zhaoyang (Megan) Li, Director, Translational Medicine & Clinical Pharmacology, Sanofi

Chris Lloyd, Senior Scientist, Protein Engineering, Antibody Discovery and Protein Engineering, MedImmune U.K. Ltd

Chris Lloyd at European Antibody Congress

Thorsten Lorenz, Group Head of Develop ability Assessment Biologics, Novartis Pharma AG

Thorsten Lorenz at European Antibody Congress

Juergen Lukas, Boehringer Ingelheim

Juergen Lukas at European Antibody Congress

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at European Antibody Congress

Mark J Mamula, Professor of Medicine Rheumatology, Yale University

Mark J Mamula at European Antibody Congress

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Dr Ivan Mascanfroni at European Antibody Congress

Justin Mason-Home, Director, HPAPI Services Limited

Justin Mason-Home at European Antibody Congress

Krzysztof Masternak, Head of Biology, NovImmune Sa

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Derek Michael Mason, PhD Candidate, ETH Zurich

Enkelejda Miho, Pioneer, ETH Zurich

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Hans-Martin Mueller, Director, Biotech Development, Millipore S.A.S.

Hans-Martin Mueller at European Antibody Congress

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Benjamí Oller-Salvia, EMBO postdoctoral fellow, M.R.C. Laboratory of Molecular Biology

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Hardev Pandha, Professor of Medical Oncology, University of Surrey

Hardev Pandha at European Antibody Congress

Nora Pencheva, Lead Scientist, Humax-AXL-ADC Program, Genmab

Nicole Piche-Nicholas, Senior Scientist, Pfizer

Nicole Piche-Nicholas at European Antibody Congress

Abhinandan Raghavan, Data Scientist, Technology and Functional Leader, Informatics, Novartis Pharma AG

Abhinandan Raghavan at European Antibody Congress

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Ulrich Rant, Chief Executive Officer, Dynamic Biosensors

Ulrich Rant at European Antibody Congress

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Theo Rispens, Group Leader, Sanquin

Christoph Roesli, Senior Fellow, Global Drug Development, Novartis Pharma AG

Yun Sanders, Senior scientist, Crescendo Biologics

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at European Antibody Congress

Darko Skegro, Senior Investigator, Biotherapeutic Technologies, Novartis Institutes for Biomedical Research

Alan K. Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Anke Steinmetz, Senior Scientist, Integrated Drug Discovery/Structure, Design & Informatics, Sanofi

Anke Steinmetz at European Antibody Congress

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Cian Stutz, Principal Scientist, Antibody Engineering, Glenmark Pharmaceuticals

Lioudmila Tchistiakova, Senior Director of Global Biotherapeutic Technologies, Pfizer

Lioudmila Tchistiakova at European Antibody Congress

Greg Thurber, Assistant Professor of Chemical Engineering, University of Michigan

Greg Thurber at European Antibody Congress

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Pascal Touchon at European Antibody Congress

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Immutep Ltd

Dr Mihriban Tuna, Vice President, Drug Discovery, F-Star

Wouter Verdurmen, Assistant Professor, Radboud University Medical Center

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Meenu Wadhwa, Section Leader for Cyotkines and Growth Factors Section, NIBSC

Meenu Wadhwa at European Antibody Congress

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Dr Martin Welschof, Chief Executive Officer, Opsona Therapeutics Ltd

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

Wei Xu, Principal Scientist, Analytical Method Development, Merck Research Laboratories

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at European Antibody Congress

 

 

European Antibody Congress:

Alain Beck , Senior Director, NBEs Analytical Chemistry, Pierre Fabre ; Associate Editor, mAbs 
Alexey Rak
, Head of Bio Structure and Biophysics, S anofi R&D
Andreas Hougaard Laustsen
, Postdoctoral Fellow, Tropical Pharmacology Lab, Technical University of Denmark 
Carl Webster, Principal Scientist
, Antibody Discovery and Protein Engineering, MedImmune
Christoph Merten
, Group Leader Microfluidics, European Molecular Biology Laboratory
Darko Skegro
, Senior Investigator, Biotherapeutic and Analytical Technologies, NIBR
Ezio Bonvini
, MD - CSO, Macrogenics
Fabian Richter
, Post-Doc, University of Stuttgart
Frank Brennan
, Senior Director, UCB Celltech
Frank Walsh
, CEO, Ossianix
Helena Domingues
, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office
Igor D’Angelo
, Team Lead, Antibody Engineering, Amgen British Colombia 
Ivan Mascanfroni
, Senior Scientist, Immunology Biologics, AbbVie
Janice Reichert
, Executive Director, The Antibody Society ; Editor-in-Chief, mABs
Jens Würthner
, Assistant Vice President, Head of Clinical Development – EU, ADC Therapeutics
Jiri Kovarik
, Research Investigator, Novartis
John Delaney
, Executive Director of Research, Amgen
Krzysztof Masternak
, Head of Biology, NovImmune
Michael Streit
, Senior Director, Clinical Leader Research, Translational Medicine and Early Development, Oncology, Janssen
Nathalie Corvaia
, Director, CIPF, Pierre Fabre
Oliver Spadiut
, Assistant Professor, Integrated Bioprocess Development, TU Wien
Patrick Burke
, Associate Director of Chemistry, Seattle Genetics
Peter Ellmark
, Principal Scientist, Immuno-Oncology, Alligator Bioscience
Peter Senter
, VP, Distinguished Research Fellow, Seattle Genetics
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Senior representative, AbCheck
Senior representative, Abzena
Senior representative, Acro Biosystems
Senior representative, BioVT
Senior representative, Fujifilm Diosynth Biotechnologies
Senior representative, Icosagen
Senior representative, Isogenica
Senior representative, KBI Biopharma
Stefan Dübel , Director, Department of Biotechnology, Technische Universität Braunschweig
Theo Rispens , Group Leader, Sanquin
Thomas Huber , Senior Investigator II, Technology Leader, Multispecific Modalities, Novartis Instituted for BioMedical Research
Ulrich Brinkmann
, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Centre Munich
William D’all Acqua
, Vice President of R&D, MedImmune
Zhaoyang (Megan) Li
, Director Clinical Pharmacology, Sanofi

 


World Immunotherapy Congress

Ahuva Nissim , Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University
Alain Vertes , Managing Director, NxR Biotechnologies
Daniela Cipolletta
, Lab Head, Investigator III, Immuno-Oncology, Novartis
Dario Neri
, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Eric Halioua
, President and Chief Executive Officer, PDC*line Pharma
Frédéric Triebel
, Chief Scientific Officer, Chief Medical Officer, Prima BioMed
Hans-Peter Gerber
, CSO, Maverick Therapeutics
Joern Schmitz
, Head, Department of Immunotherapy, Fraunhofer IME
Jose Saro
, Senior Translational Medicine Leader, Roche
M. Anthony Moody
, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre
Martin Welschof
, Chief Executive Officer, Opsona Therapeutics
Martina Canestraro
, Senior Research Scientist, Immunocore
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Shane Olwill
, Head of Immuno-Oncology, Pieris Pharmaceuticals 
Sidath Katagampola
, Biomarker Development Sciensist, Centre for Drug Development, Cancer Research UK

 


Clinical Trials


Stephen Nabarro , Head Clinical ops and data, Cancer Research UK
Jonathan Sheffield
, CEO, NIHR
Jim Kremidas,
 Director,  Association of Clinical Research Professionals 
Andy Lee
, Head of Global Clinical Trial Operations, Novartis 
Eileen Dergarabetian
, Head of Medical Information and engagement, Novartis
Joana Claverol
, Clinical Research Unit Manager, Sant Joan de Deu Barcelona Children's Hospital, Research Foundation
Suvodip Shaw
, Global Central Monitoring Operations Manager, Novartis

 


World Biosimilar Congress


Adam Levysohn , Sr Director Market Access Biosimilar, Biogen
Alain Beck
, Senior Director Analytical Chemistry, CIPF and Associate Editor, mAbs
Alain Vertes
, Managing Director, NxR Biotechnologies
Ber Oomen
, Executive Secretary, European Specialist Nurses Organisations
Cecil Nick
, Vice President, Biotechnology, PAREXEL
Divya Chadha Manek
, Head of Commercial Business Development & Marketing, NIHR Clinical Research Network (NIHR CRN)
Gianluca Trifirò
, Department of Biomedical Sciences, Dentistry and Morphological and Functional Images, University of Messina – Italy
Ian Henshaw
, Global Head of Business Operations and Alliance Management, Biogen
Ingrid Schwarzenberger
, Head Global Regulatory Affairs, Sandoz Biopharmaceuticals
Jatinder Harchowal
, Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Pharmacy Dept, The Royal Marsden NHS Foundation Trust
Jonathan Underhill
, Medicines Clinical Adviser, Medicines and Technologies Programme (MTP), NICE
Karsten Roth
, Director Clinical Operations and Pharmacovigilance, Cinfa Biotech GmbH
Philip Ball
, Market Access Manager, NAPP Pharmaceuticals
Ruediger Jankowsky
, Managing Director, Cinfa Biotech GmbH
Shantreddy Soogareddy
, Associate Director External R&D, Dr. Reddy's Laboratories SA.
Steinar Madsen
, Medical Director, Norwegian Medicines Agency
Tim Shea
, Director, Sterne, Kessler, Goldstein & Fox
Uwe Gudat
, Head of Safety, Biosimilars, Merck

 


HPAPI World Congress


Wendel Doubleday , Sr Director, Process Research and Development, Seattle Genetics 
Karoline Betchtold Peters
, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis
Justin Mason Home,
Director, HPAPI Project Services Ltd
Martin Axon
, Principle Occupational Hygienist, SafeBridge  
Marc Abromovitz
, Director, Occupational Health and Hygiene, Novartis  
Ildiko Ziegler
, Distinguished Validation Expert, Gedeon Richter
Reinhold Maeck
, Associate Director Tech-Transfers, Boehringer Ingelheim
Andreas Schreiner
, Director of Validation, Manufacturing Science and Technology, Novartis 
González Borroto
, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.Toral 
Toral Mehta
, Head of Industrial Hygiene and Containment, Sandoz 
Jack Brown
, Sr Principle Scientist, Boehringer Ingelheim
Juergen Knoebel
, Senior Advisor - Global Technical Operations Quality Systems/Quality Management, Roche
Alessandro Brigo
, Principal Scientist, Roche

 

 

 

2017 Speakers

 

Eric A Hughes, Development Unit Head, Immunology & Dermatology, Novartis

Eric A Hughes at European Antibody Congress

Marc Abromovitz, Head, Industrial Hygiene, Novartis

Marc Abromovitz at European Antibody Congress

Dr Rafael Amado, Chief Medical Officer, Adaptimmune

Dr Rafael Amado at European Antibody Congress

Prof Steve Anderton, Chief Scientific Officer, Aquila BioMedical

Prof Steve Anderton at European Antibody Congress

Dr Sagrario Arias Rivas, Principal Scientist and Project Manager, Batavia Biosciences

Dr Sagrario Arias Rivas at European Antibody Congress

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Tudor Arvinte at European Antibody Congress

Michael Avraam, Global Product Manager, ChargePoint Technology Ltd

Michael Avraam at European Antibody Congress

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at European Antibody Congress

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Philip Ball at European Antibody Congress

Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University

Fereshteh Barei at European Antibody Congress

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Dr Roy Baynes at European Antibody Congress

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, F. Hoffmann-La Roche Ltd

Karoline Bechtold Peters at European Antibody Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Dr Alain Beck at European Antibody Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Dr Alain Beck at European Antibody Congress

Roger Beerli, CSO, NBE Therapeutics

Roger Beerli at European Antibody Congress

Gary Bembridge, Senior Director Scientific Affairs – Immunology, Business Development, Abzena

Gary Bembridge at European Antibody Congress

Dr Ezio Bonvini, CSO, Macrogenics

Dr Ezio Bonvini at European Antibody Congress

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh

Caroline Boulliat at European Antibody Congress

Dr Renier Brentjens, Director, Cellular Therapeutics, Memorial Sloan-Kettering Cancer Center

Dr Renier Brentjens at European Antibody Congress

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Dr Ulrich Brinkmann at European Antibody Congress

Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC

Joanna Brougher at European Antibody Congress

Stefano Butti, Head of Sales Group, F.P.S. Food and Pharma Systems Srl

Stefano Butti at European Antibody Congress

Martina Canestraro, Senior Research Scientist, Immunocore Ltd

Martina Canestraro at European Antibody Congress

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Divya Chadha Manek at European Antibody Congress

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Andre Choo at European Antibody Congress

Dr Sarah Ciangerani, Head of the BioOrganic Mass Spectrometry Laboratory, CNRS UMR7178, University of Strasbourg

Dr Sarah Ciangerani at European Antibody Congress

Dan Cimpoeru, Board Member, European Cancer Patient Coalition

Dan Cimpoeru at European Antibody Congress

Jeremy Clarke, Director of Commercial Development, Asterand Bioscience

Jeremy Clarke at European Antibody Congress

Anne Cook, Biologicals Quality Assessor, M.H.R.A.

Anne Cook at European Antibody Congress

Nazanin Dadehbeigi, Principal Scientist, Fujifilm Diosynth Biotechnologies

Nazanin Dadehbeigi at European Antibody Congress

Dr Jonathan Davis, Principal Scientist, Molecular Structure and Design, Bristol Myers Squibb

Dr Jonathan Davis at European Antibody Congress

Lee Dawson, Senior Scientist, Molecular Pathology Group, Asterand Bioscience

Lee Dawson at European Antibody Congress

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Dr John Delaney at European Antibody Congress

Dr Kangwen Deng, Senior Scientist, AbbVie

Dr Kangwen Deng at European Antibody Congress

Dr Michael DeRidder, Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD, GSK

Dr Michael DeRidder at European Antibody Congress

Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.

Margaret Dolan at European Antibody Congress

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at European Antibody Congress

Prof Stefan Dübel, Director, Department of Biotechnology, Braunschweig University of Technology

Prof Stefan Dübel at European Antibody Congress

Pieter Dylst, Senior Manager Market Access, Medicines for Europe

Pieter Dylst at European Antibody Congress

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Dr Peter Ellmark at European Antibody Congress

Dr Seth Ettenberg, Chief Scientific Officer, Unum Therapeutics Inc.

Dr Seth Ettenberg at European Antibody Congress

Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd

Catherine Evans at European Antibody Congress

Dr Joachim Feldwisch, Director of Preclinical Development, Affibody Ab

Dr Joachim Feldwisch at European Antibody Congress

Dr Nicolas Fischer, Head for Research, Novimmune Sa

Dr Nicolas Fischer at European Antibody Congress

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Mathias Flume at European Antibody Congress

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

Francois Xavier Frapaise MD at European Antibody Congress

Dr Jim Freeth, Managing Director, Retrogenix

Dr Jim Freeth at European Antibody Congress

Dr Jim Freeth, Managing Director, Retrogenix

Dr Jim Freeth at European Antibody Congress

Dr David Gilham, Vice President of Research and Development, Celyad

Dr David Gilham at European Antibody Congress

Ralf Gleixner, Head - Global Regulatory Affairs CMC, Merck

Ralf Gleixner at European Antibody Congress

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at European Antibody Congress

Dr Andrea Gonzalez-Munoz, Research Associate, Medimmune

Dr Andrea Gonzalez-Munoz at European Antibody Congress

Dr Ulf Grawunder, Chief Executive Officer & Founder, NBE Therapeutics

Dr Ulf Grawunder at European Antibody Congress

Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie

Uwe Gudat at European Antibody Congress

Dr Guanghui Han, Scientific Manager, Genentech

Dr Guanghui Han at European Antibody Congress

Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust

Jatinder Harchowal at European Antibody Congress

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Dr Steffen Hartmann at European Antibody Congress

Dr Haruki Hasegawa, Principal Scientist, Amgen

Dr Haruki Hasegawa at European Antibody Congress

Professor Robert Hawkins, CEO and Co-founder, Cellular Therapeutics Ltd

Professor Robert Hawkins at European Antibody Congress

Dr Peer Heine, Field Applications Scientist, Europe, MaxCyte

Dr Peer Heine at European Antibody Congress

Helena Hemming, Senior Occupational Toxicologist, AstraZeneca

Helena Hemming at European Antibody Congress

Ian Henshaw, Head of Business Operations, Biogen

Ian Henshaw at European Antibody Congress

Forrest Hu, General Manager of International Business, 3SBio Inc

Forrest Hu at European Antibody Congress

Dr Yue Huang, Head of Clinical Pharmacology China, Merck

Dr Yue Huang at European Antibody Congress

Dr Greta Hultqvist, Assistant Professor, Uppsala University

Dr Greta Hultqvist at European Antibody Congress

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at European Antibody Congress

Dr Lutz Jermutus, Senior Director and Global Head of Technology, MedImmune Cambridge

Dr Lutz Jermutus at European Antibody Congress

Ulf Johansson, Project Manager, AstraZeneca

Ulf Johansson at European Antibody Congress

Dr Syd Johnson, Vice President of Antibody Engineering, Macrogenics

Dr Syd Johnson at European Antibody Congress

Dr Karin Jooss, Executive Vice President of Research, and Chief Scientific Officer, Gritstone Oncology

Dr Karin Jooss at European Antibody Congress

Peter Jorgensen, Chief Executive Officer, I.G.L.

Peter Jorgensen at European Antibody Congress

Dr Milena Kalaitsidou, Post Doctoral Research Associate (University of Manchester), GSK

Dr Milena Kalaitsidou at European Antibody Congress

Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly and Co

Michael Kalos at European Antibody Congress

Dr Sidath Katugampola, Biomarker Development Specialist, Cancer Research U.K. Cambridge Institute

Dr Sidath Katugampola at European Antibody Congress

Parminder Kaur, CEO, RegPak BioPharma Consulting

Parminder Kaur at European Antibody Congress

Dr Thomas Keating, Director of Biochemistry, Immunogen, Inc.

Dr Thomas Keating at European Antibody Congress

Alex Kelly, European Business Development Executive, Retrogenix

Alex Kelly at European Antibody Congress

Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc

Tarek Kilani at European Antibody Congress

Dr Christian Klein, Head Oncology Programs, Roche Pharmaceutical Research and Early Development

Dr Christian Klein at European Antibody Congress

Dr Christian Kleusch, Application Specialist, NanoTemper

Dr Christian Kleusch at European Antibody Congress

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Martin Knight at European Antibody Congress

Jenny Koppelkamm, Market Access Director, Takeda

Jenny Koppelkamm at European Antibody Congress

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Dr Jiri Kovarik at European Antibody Congress

Dr Carsten Kranz, Investigator III, Novartis

Dr Carsten Kranz at European Antibody Congress

William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc

William Christopher Lamanna at European Antibody Congress

Dr Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Dr Andreas Hougaard Laustsen at European Antibody Congress

Olindo Lazzaro, Director, Environment, Health & Safety, AbbVie

Olindo Lazzaro at European Antibody Congress

Dr Marie-Paule LeFranc, Professor Emeritus, Universite De Montpellier

Dr Marie-Paule LeFranc at European Antibody Congress

Dr James Legg, Vice President, Research and Development, Crescendo Biologics Ltd

Dr James Legg at European Antibody Congress

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Adam Levysohn at European Antibody Congress

Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.

Patrick Liu at European Antibody Congress

Ester Lovsin Barle, Head of Health Hazard Assessment Center of Excellence, Lonza

Ester Lovsin Barle at European Antibody Congress

Brian Lundstrom, Vice President of O.M.T. and C.B.O., Ligand Pharmaceuticals, Inc.

Brian Lundstrom at European Antibody Congress

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at European Antibody Congress

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at European Antibody Congress

Sara Martens, Senior Manager, OH/Containment, AbbVie

Sara Martens at European Antibody Congress

Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda

Márcia Martini Bueno at European Antibody Congress

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Dr Ivan Mascanfroni at European Antibody Congress

Justin Mason-Home, Director, HPAPI Services Limited

Justin Mason-Home at European Antibody Congress

Steve McAleavy, Director, Ezi Dock Systems Ltd

Steve McAleavy at European Antibody Congress

Stewart McNaull, Senior VP, Business Development, KBI Biopharma

Stewart McNaull at European Antibody Congress

Dr Patrick Mehlen, Chief Executive Officer, Netris Pharma

Dr Patrick Mehlen at European Antibody Congress

Dr David Meininger, Chief Business Officer, Trianni Inc

Dr David Meininger at European Antibody Congress

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Victor Lino Mendonça at European Antibody Congress

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Dr Christoph Merten at European Antibody Congress

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Vera Molkenthin at European Antibody Congress

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Dr M. Anthony Moody at European Antibody Congress

Carla Mouta-Bellum, Finnegan Henderson Farabow Garrett and Dunner Llp

Carla Mouta-Bellum at European Antibody Congress

Dr Mostafa Nakach, Head of Pharmaceutical Engineering, Sanofi Aventis

Dr Mostafa Nakach at European Antibody Congress

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Gopalan Narayanan at European Antibody Congress

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Prof Dr Dario Neri at European Antibody Congress

Cecil Nick, Vice President, PAREXEL

Cecil Nick at European Antibody Congress

Rainer Nicolai, Technical Specialist, F. Hoffmann-La Roche Ltd

Rainer Nicolai at European Antibody Congress

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Dr Ahuva Nissim at European Antibody Congress

Dr Victor Obungu, Principal Research Scientist, Eli Lilly and Company

Dr Victor Obungu at European Antibody Congress

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Dr Shane Olwill at European Antibody Congress

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Ber Oomen at European Antibody Congress

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Mareike Ostertag at European Antibody Congress

Dr Angie Inkyung Park, Sr. Director of Immunotherapy and Stem Cells, Oncomed Pharmaceuticals

Dr Angie Inkyung Park at European Antibody Congress

Jeff Parry, Senior Scientist Manufacturability, AstraZeneca

Jeff Parry at European Antibody Congress

Aurore Perzyna, Head of Production, Oril Industrie

Aurore Perzyna at European Antibody Congress

Sari Pesonen, VP Scientific and Clinical Development, Co-Founder, Valo Therapeutics

Sari Pesonen at European Antibody Congress

Prof. Andreas Plueckthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Dept. of Biochemistry

Prof. Andreas Plueckthun at European Antibody Congress

Laurent Poirot, Head of Early Discovery, Cellectis

Laurent Poirot at European Antibody Congress

Sylvain Querol, European Technical and Tendering Manager, Powder Systems Limited (PSL)

Sylvain Querol at European Antibody Congress

Dr Alfonso Quintas, Head of Clinical Development, Cell Therapy, GSK

Dr Alfonso Quintas at European Antibody Congress

Dr Christoph Rader, Associate Professor, The Scripps Research Institute

Dr Christoph Rader at European Antibody Congress

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Dr Alexey Rak at European Antibody Congress

Dr Sai Reddy, Assistant Professor of Bimolecular Engineering, E.T.H. Zurich

Dr Sai Reddy at European Antibody Congress

Dr Janice Reichert, Executive Director, The Antibody Society

Dr Janice Reichert at European Antibody Congress

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Michael Reilly at European Antibody Congress

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Dr Fabian Richter at European Antibody Congress

Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars

Joaquin Rodrigo at European Antibody Congress

Dr Christian Rommel, Global Head of Oncology Discovery, F Hoffman La Roche Ltd

Dr Christian Rommel at European Antibody Congress

Dr Stacie Ropka, Partner, Axinn

Dr Stacie Ropka at European Antibody Congress

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Karsten Roth at European Antibody Congress

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Jerald Sadoff at European Antibody Congress

Dr Puja Sapra, Vice President and Chief Scientific Officer, Targeted Therapeutics Discovery, Oncology R&D, Pfizer Biotherapeutics

Dr Puja Sapra at European Antibody Congress

Dr Jose Saro, T.M.L. Pharma Research and Early Development, Oncology, Roche

Dr Jose Saro at European Antibody Congress

Dr Volker Schellenberger, Chief Executive Officer & President, Amunix Inc

Dr Volker Schellenberger at European Antibody Congress

Joern Schmitz, Department Head, Fraunhofer I.M.E.

Joern Schmitz at European Antibody Congress

Dr Mike Schopperle, Chief Executive Officer, CureMeta Llc

Dr Mike Schopperle at European Antibody Congress

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at European Antibody Congress

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Ingrid Schwarzenberger at European Antibody Congress

Claudia Sehner, Principal Scientist Toxicology, Boehringer Ingelheim Pharma GmbH & Co. KG

Claudia Sehner at European Antibody Congress

Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd

Anjan Selz at European Antibody Congress

Dr Marjorie Shapiro, Chief of Laboratory of Molecular and Developmental Immunology, CDER, FDA

Dr Marjorie Shapiro at European Antibody Congress

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Tim Shea at European Antibody Congress

Darko Skegro, Senior Investigator, Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research

Darko Skegro at European Antibody Congress

Jae Sly, Director of Strategic Business Development, ACRO Biosystems Inc

Jae Sly at European Antibody Congress

Jae Sly, Director of Strategic Business Development, ACRO Biosystems Inc

Jae Sly at European Antibody Congress

Dr James Smith, Research Associate, C.A.S.M.I. University of Oxford

Dr James Smith at European Antibody Congress

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Shantreddy Soogareddy at European Antibody Congress

Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology

Dr Oliver Spadiut at European Antibody Congress

Mark Spengler, Director, Project Management, Chimera Biotec GmbH

Mark Spengler at European Antibody Congress

George Stefanov, Marketing Operations Director Biologics, Europe, Mylan

George Stefanov at European Antibody Congress

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Don Stewart at European Antibody Congress

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Pawel Stocki at European Antibody Congress

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Dr Michael Streit at European Antibody Congress

Marc Suter, Sr Sales Manager, Skan A.G.

Marc Suter at European Antibody Congress

Dr Martin Treder, Chief Scientific Officer, Affimed Therapeutics Ag

Dr Martin Treder at European Antibody Congress

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd

Dr Frédéric Triebel at European Antibody Congress

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Gianluca Trifirò at European Antibody Congress

Anubhav Tripathi, Professor of Bioengineering and Medical Science, Brown University

Anubhav Tripathi at European Antibody Congress

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at European Antibody Congress

Peter Ulrich, Safety Assessment Expert, Novartis Institutes for Biomedical Research

Peter Ulrich at European Antibody Congress

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at European Antibody Congress

Dr Timo Van Den Berg, Professor of Immunotherapy, Head of Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory

Dr Timo Van Den Berg at European Antibody Congress

Steve Vance, Senior Scientist, Crescendo Biologics Ltd

Steve Vance at European Antibody Congress

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Dr Alain Vertes at European Antibody Congress

Dr Feng Wang, Principle Investigator, Biology, Calibr - California Institute for Biomedical Research

Dr Feng Wang at European Antibody Congress

Silke Weber, Toxicology Project Lead, Roche

Silke Weber at European Antibody Congress

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Dr Carl Webster at European Antibody Congress

Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research

Manfred Weiler at European Antibody Congress

Dr Martin Welschof, Chief Executive Officer, Opsona Therapeutics Ltd

Dr Martin Welschof at European Antibody Congress

Dr Andreas Wiesner, Global Product Manager Cell Culture Media, Sartorius Stedim Biotech U.K.

Dr Andreas Wiesner at European Antibody Congress

Sir Gregory Winter, Master, Trinity College Cambridge, University of Cambridge

Sir Gregory Winter at European Antibody Congress

Sir Gregory Winter, Master, Trinity College Cambridge, University of Cambridge

Sir Gregory Winter at European Antibody Congress

Robert Wojciechowski, Vice President, Global Regulatory Consulting, INC Research/inVentiv Health

Robert Wojciechowski at European Antibody Congress

Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut

Elena Wolff-Holz at European Antibody Congress

Francis Wollerton, Director of Antibody Engineering, F-star Biotechnology Ltd

Francis Wollerton at European Antibody Congress

Jesper Worm, Scientist, CMC Biologics

Jesper Worm at European Antibody Congress

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

Dr Jens Würthner at European Antibody Congress

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.

René Wuttke at European Antibody Congress

Jiannian Zhou, Director of Assay Development, ACRO Biosystems Inc

Jiannian Zhou at European Antibody Congress

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at European Antibody Congress

 

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates